Moderna Stock Rises Following Recent Developments
Moderna (NASDAQ: MRNA) saw its stock rise 5.5% after the FDA indicated it would accept the company's application for a ...
Tag: Moderna
US to Review Previously Declined Moderna Flu Vaccine
The pharmaceutical giant Moderna expressed optimism that its new flu shot will be available this year after the FDA accepted ...
FDA Rejects Review of Moderna Flu Vaccine
The FDA has declined to review Moderna's flu vaccine application, citing insufficient data and questioning the product's adherence to standard ...
Moderna’s mRNA flu vaccine application rejected by FDA
The FDA has rejected Moderna's application for a new flu vaccine utilizing mRNA technology, citing inadequate clinical trial comparisons. This ...
Consider This Alternative to Moderna Stock
Investors initially flocked to Moderna (NASDAQ: MRNA) for its highly sought-after coronavirus vaccine, which rapidly transformed the company from a ...
Should You Sell Your Moderna Shares?
Moderna (NASDAQ: MRNA) gained recognition for its role in developing a COVID-19 vaccine using innovative messenger RNA (mRNA) technology, which ...
Moderna’s new COVID-19 vaccine mNexspike approved by FDA, but there’s a limit on who can use it
The U.S. has approved Moderna's new COVID-19 vaccine, mNexspike, which is a lower-dose option targeting high-risk individuals aged 65 and ...
Why Moderna Stock Was Down 31.8% in Q1 as the S&P 500 Had Its Worst Quarter Since 2022
The first quarter of 2025 was challenging for Moderna, with shares sliding 31.8% as the S&P 500 and Nasdaq Composite ...
News Summarized. Time Saved. Bite-sized news briefs for busy people. No fluff, just facts.